🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Service Response and Material Removal

According to TikTok, the platform has taken down violative content and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for mixing or injecting at home.

Within moments of joining one group, a vendor posted WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these groups, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to potentially significant health risks”.